ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

March 28, 1986

Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate.

October 10, 2008

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982

JR Adams Elected President, Ovarian Cancer Coalition.

March 9, 2001